Table 4.
Five-year relative survival rates among patients diagnosed with cutaneous lymphoma during 1992-2000 in the 16 SEER program registries by histologic type, sex, and race
| Total |
Males |
Females |
Whites |
Blacks |
|||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| No. | SR, % | SE, % | No. | SR, % | SE, % | No. | SR, % | SE, % | No. | SR, % | SE, % | No. | SR, % | SE, % | |
| Mature T-cell and NK-cell neoplasms (CTCLs) | 2270 | 85.4 | 1.0 | 1331 | 84.5 | 1.0 | 939 | 87.6 | 1.5 | 1636 | 87.3 | 1.2 | 306 | 81.8 | 2.8 |
| Mycosis fungoides (MF) | 1403 | 90.9 | 1.2 | 793 | 91.9 | 1.0 | 610 | 91.3 | 1.7 | 976 | 92.8 | 1.5 | 219 | 85.1 | 3.2 |
| Sézary syndrome (SS) | 45 | 39.5 | 8.6 | 28 | 31.6 | 10.6 | 17 | 50.8 | 14.1 | 35 | 45.0 | 10.3 | 5 | ∼† | ∼ |
| CD30+ lymphoproliferative disorders (CD30+ LPD) | 100‡ | 73.1 | 5.2 | 72 | 67.3 | 5.0 | 28 | 80.6 | 9.0 | 70 | 78.6 | 5.9 | 11 | 75.6 | 14.5 |
| Primary cutaneous peripheral T-cell lymphoma (pcPTL) | 722 | 79.1 | 2.0 | 438 | 75.7 | 2.0 | 284 | 81.8 | 2.9 | 555 | 80.8 | 2.2 | 71 | 75.2 | 6.3 |
| Mature B-cell neoplasms (CBCLs) | 610 | 86.5 | 2.1 | 348 | 86.2 | 2.7 | 262 | 85.7 | 3.4 | 498 | 87.1 | 2.4 | 25 | 83.3 | 9.9 |
| Cutaneous marginal zone B-cell lymphoma (pcMZL) | 98‡ | 93.1 | 4.4 | 56 | 91.5 | 5.9 | 42 | 93.9 | 6.5 | 70 | 93.9 | 5.4 | 3 | ∼ | ∼ |
| Cutaneous follicle center lymphoma (pcFCL) | 162 | 96.2 | 3.5 | 84 | 94.7 | 4.5 | 78 | 96.0 | 5.4 | 146 | 95.1 | 3.8 | 6 | ∼ | ∼ |
| Cutaneous diffuse large B-cell lymphoma (pcDLBCL) | 290 | 77.3 | 3.4 | 179 | 80.7 | 4.0 | 111 | 68.8 | 6.0 | 238 | 79.7 | 3.8 | 14 | 72.2 | 14.9 |
| pcDLBCL-leg | 48 | 46.3 | 9.4 | 31 | 48.9 | 11.7 | 17 | 38.4 | 15.7 | 41 | 49.7 | 10.7 | 3 | ∼ | ∼ |
| pcDLBCL-other | 242 | 81.2 | 3.4 | 148 | 85.9 | 4.0 | 94 | 72.8 | 6.3 | 197 | 83.8 | 3.8 | 11 | 85.7 | 13.9 |
| Extracutaneous lymphomas involving the skin* | 60 | 88.6 | 5.9 | 29 | 75.7 | 9.8 | 31 | 98.1 | 6.1 | 44 | 83.9 | 7.5 | 2 | ∼ | ∼ |
The period of survival was from the date of diagnosis to the date of last contact, death, or December 31, 2005.
The registries include 2318 cases diagnosed during 1992-1999 in the SEER 12 and 562 cases diagnosed during 2000 in the SEER 16 registries.
Relative survival rates were available only for whites and blacks and were not yet available for Hispanics and Asian/Pacific Islanders, thus Hispanics and Asian/Pacific Islanders were excluded from race-specific survival analyses (n = 415).
SR indicates survival rate; and SE, standard error.
This group includes small lymphocytic lymphoma, lymphoplasmacytic lymphoma, mantle cell lymphoma, and Burkitt lymphoma.
Statistic not shown, based on fewer than 10 cases.
CD30+ LPD and cutaneous marginal zone B-cell lymphoma were first recognized in the third edition of the WHO's ICD-O. There were 100 cases of CD30+ LPD and 98 cases of pcMBL diagnosed in 2000.